Search Within

Tiffany A Traina

Formats
  1. Meeting Abstract (140)
  2. Journal Article (95)
  3. Book Section (8)
  4. Review (7)
  5. Book Whole (2)
  6. Guidelines (1)
  7. Miscellaneous (1)
Groups
  1. Breast Medicine Service (254)
  2. Department of Medicine (254)
  3. Solid Tumor Oncology Division (254)
  4. Survivorship Research (254)
  5. Epidemiology and Biostatistics (101)
  6. Biostatistics Service (87)

More Groups

People
  1. Clifford Hudis (95)
  2. Sujata Patil (62)
  3. Ayca Gucalp (59)
  4. Larry Norton (56)
  5. Maura Dickler (34)
  6. Diana Lake (33)

More People

Years
  1. 2025 (7)
  2. 2024 (16)
  3. 2023 (8)
  4. 2022 (13)
  5. 2021 (17)
  6. 2020 (16)

More Years

Publications
  1. Journal of Clinical Oncology (79)
  2. Cancer Research (44)
  3. Breast Cancer Research and Treatment (16)
  4. Annals of Oncology (14)
  5. Clinical Cancer Research (11)
  6. Clinical Breast Cancer (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (80)
  2. American Association for Cancer Research (55)
  3. Springer (33)
  4. Elsevier Inc. (24)
  5. Oxford University Press (16)
  6. Future Medicine (5)

More Publishers

Results (254)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer with cardiac biomarker data
    Meeting Abstract

    Iyengar, N. M.; Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Goldfarb, S.; Theodoulou, M.; Lake, D.; Fornier, M. N.; Modi, S.; Fasano, J.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • A phase 2 single-arm study of the clinical activity and safety of enzalutamide in patients with advanced androgen receptor-positive triple-negative breast cancer
    Meeting Abstract

    Traina, T. A.; O'Shaughnessy, J.; Kelly, C.; Schwartzberg, L.; Gucalp, A.; Peterson, A.; Bhattacharya, S.; Trudeau, M.; Hudis, C. A.; Schmid, P.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Significance of circulating tumor cells in metastatic triple negative breast cancer: Results of an open label, randomized, phase II trial of nanoparticle albumin-bound paclitaxel with or without the anti-death receptor 5 tigatuzumab (TBCRC 019)
    Meeting Abstract

    Paoletti, C.; Li, Y.; Muñiz, M. C.; Kidwell, K. M.; Aung, K.; Thomas, D. G.; Brown, M. E.; Abramson, V.; Irvin, W. J. Jr; Lin, N. U.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Understanding triple-negative breast cancer
    Book Section

    Gucalp, A.; Traina, T. A.
    In Ahmad, A. (Eds.) Breast Cancer Metastasis and Drug Resistance: Progress and Prospects (2013)

    Fulltext@MSK | Save
  • Cognitive effects of cancer and its treatments at the intersection of aging: What do we know; What do we need to know?
    Journal Article

    Mandelblatt, J. S.; Hurria, A.; McDonald, B. C.; Saykin, A. J.; Stern, R. A.; Vanmeter, J. W.; McGuckin, M.; Traina, T.; Denduluri, N.; Turner, S.; more...
    Seminars in Oncology (2013)

    Fulltext@MSK | Save
  • Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic breast cancer
    Journal Article

    Gucalp, A.; Tolaney, S.; Isakoff, S. J.; Ingle, J. N.; Liu, M. C.; Carey, L. A.; Blackwell, K.; Rugo, H.; Nabell, L.; Forero, A.; more...
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • Breast-conserving therapy achieves locoregional outcomes comparable to mastectomy in women with T1-2N0 triple-negative breast cancer
    Journal Article

    Zumsteg, Z. S.; Morrow, M.; Arnold, B.; Zheng, J.; Zhang, Z.; Robson, M.; Traina, T.; McCormick, B.; Powell, S.; Ho, A. Y.
    Annals of Surgical Oncology (2013)

    Fulltext@MSK | Save
  • Advances in Molecular and Clinical Subtyping of Breast Cancer and Their Implications for Therapy
    Journal Article

    Cadoo, K. A.; Traina, T. A.; King, T. A.
    Surgical Oncology Clinics of North America (2013)

    Fulltext@MSK | Save
  • The role of the androgen receptor in triple-negative breast cancer
    Journal Article

    Shah, P. D.; Gucalp, A.; Traina, T. A.
    Women's Health (2013)

    Fulltext@MSK | Save
  • Black race as a prognostic factor in triple-negative breast cancer patients treated with breast-conserving therapy: A large, single-institution retrospective analysis
    Journal Article

    Perez, C. A.; Zumsteg, Z. S.; Gupta, G.; Morrow, M.; Arnold, B.; Patil, S. M.; Traina, T. A.; Robson, M. E.; Wen, Y. H.; McCormick, B.; more...
    Breast Cancer Research and Treatment (2013)

    Fulltext@MSK | Save